相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis
Michael A. Castello et al.
AGEING RESEARCH REVIEWS (2014)
The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
David A. Drachman
ALZHEIMERS & DEMENTIA (2014)
The role of amyloid-beta in the regulation of memory
John E. Morley et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque
Jason P. Holland et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2014)
Antiamyloid Therapy for Alzheimer's Disease - Are We on the Right Road?
Eric Karran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Rational heterodoxy: Cholesterol reformation of the amyloid doctrine
Michael A. Castello et al.
AGEING RESEARCH REVIEWS (2013)
Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease
Chaoyun Li et al.
AGEING RESEARCH REVIEWS (2013)
Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls
Thomas J. Esparza et al.
ANNALS OF NEUROLOGY (2013)
Intranasal Insulin as a Treatment for Alzheimer's Disease: A Review of Basic Research and Clinical Evidence
Jessica Freiherr et al.
CNS DRUGS (2013)
Amyloid β precursor protein as a molecular target for amyloid β-induced neuronal degeneration in Alzheimer's disease
Elena Anahi Bignante et al.
NEUROBIOLOGY OF AGING (2013)
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity
Clifford R. Jack et al.
NEUROLOGY (2013)
Valproate reopens critical-period learning of absolute pitch
Judit Geryain et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides
Jitin Bali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy
Vincent T. Marchesi
FASEB JOURNAL (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'
Rudy J. Castellani et al.
JOURNAL OF PATHOLOGY (2011)
Modeling cholesterol metabolism by gene expression profiling in the hippocampus
Christopher M. Valdez et al.
MOLECULAR BIOSYSTEMS (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Reimagining Alzheimer's Disease-An Age-Based Hypothesis
Karl Herrup
JOURNAL OF NEUROSCIENCE (2010)
Amyloid beta mediates memory formation
Ana Garcia-Osta et al.
LEARNING & MEMORY (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2008)
Amyloid-β in Alzheimer disease:: The null versus the alternate hypotheses
Hyoung-gon Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Neuropathology of cognitively normal elderly
DS Knopman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
分享论文
